‘ ETF Industry News ’

UBS launches currency-hedged US multifactor ETF on SIX

Sep 8th, 2017 | By
UBS launches currency-hedged US multifactor ETF on SIX

UBS has listed three share classes of the UBS MSCI USA Select Factor Mix ETF on Switzerland’s SIX Exchange, providing currency-hedged multifactor exposure to US equities. The three share classes offer investors the choice of currency hedging between the US dollar and sterling, euros, or swiss francs.



Goldman Sachs launches smart beta HY corporate bond ETF

Sep 8th, 2017 | By
Goldman Sachs launches smart beta high yield corporate bond ETF

Goldman Sachs Asset Management (GSAM) has launched the Goldman Sachs Access High Yield Corporate Bond ETF (NYSE Arca: GHYB), offering smart beta exposure to US dollar-denominated high yield corporate bond markets.



BlackRock introduces currency hedged versions of floating rate bond ETF

Sep 8th, 2017 | By
BlackRock to transfer 50 iShares ETFs to Nasdaq or Bats

BlackRock has introduced GBP and EUR hedged versions of its iShares USD Floating Rate Bond UCITS ETF (LON: FLOT). The move comes at a time when the dollar is losing ground against other major currencies which may be discouraging investors from holding unhedged dollar-denominated assets.



Tradeweb reports strong buying of fixed income ETFs during August

Sep 8th, 2017 | By
Tradeweb reports strong buying of fixed income ETFs during August

Tradeweb has reported that fixed income ETFs saw net buying activity on its European-listed ETF marketplace during August with ‘buys’ outperforming ‘sells’ by six percentage points.



Strategic beta ETFs simply repackage risk, finds Morningstar

Sep 8th, 2017 | By
ETF providers take action to improve transparency and safeguards around securities lending

Strategic beta ETFs (also widely known as smart beta ETFs) may not be as distinctive as advertised – market capitalisation weighted ETFs may be able to capture some of the performance drivers of strategic beta alternatives at a lower cost, finds Morningstar.



FTSE 100 & 250 ETFs set for reshuffle following quarterly index review

Sep 7th, 2017 | By
FTSE 100 ETFs rally as index passes 7,500

ETFs tracking the FTSE 100 and FTSE 250 are set for a reshuffle following the latest quarterly review from index provider FTSE Russell. Changes to the blue-chip FTSE 100, underlying index to the £5bn iShares Core FTSE 100 UCITS ETF (ISF), will see NMC Health and Berkeley Group added at the expense of Provident Financial and Royal Mail.



FTSE Russell announces changes to the Industry Classification Benchmark

Sep 7th, 2017 | By
Creation of official GICS real estate sector to change MSCI- and S&P-linked ETFs

Index provider FTSE Russell has announced changes to its Industry Classification Benchmark (ICB), a classification taxonomy used to segregate markets into industries and sectors. The adjustments include real estate becoming the eleventh ICB Industry, as well as a reshuffle of the telecommunications sector to better reflect the present state of industry evolution.



WisdomTree: Gold may climb to $1,400/oz in near term

Sep 7th, 2017 | By
Precious metals ETFs lose their lustre

Gold ETPs could be set to benefit from a spike in the gold price, according to new market commentary from WisdomTree. Nazim Hamid, ETF strategist at WisdomTree thinks the spot gold price could climb as high as $1,400 in the near term, due to political uncertainty and increased interest from hedge funds.



Smart Beta vs Factors in Portfolio Construction

Sep 6th, 2017 | By
Smart Beta vs Factors in Portfolio Construction

By Nicolas Rabener, Founder, FactorResearch.

FTSE Russell’s 2017 Smart Beta Investor Survey showed that the Number 1 objective for evaluating smart beta strategies was for risk reduction, followed by return enhancement. Naturally there are many types of smart beta strategies available to investors today, however, they are nearly all long-only products. If equity markets crash, then smart beta products will also crash and would not substantially reduce portfolio risks.



Healthtech ETFs get shot in the arm

Sep 6th, 2017 | By
Healthtech ETFs get shot in the arm

ETFs tracking biotechnology and healthcare technology equities have posted impressive recent performance: since 21 August 2017, the Source NASDAQ Biotech UCITS ETF (LON: SBIO) is up 10.2% and the iShares Healthcare Innovation UCITS ETF (LON: HEAL) has returned 5.6%. In comparison, the S&P 500 rose just 2.0% over the same period.